Hong Kong stocks fluctuate | WuXi Biologics (02269.HK) rose over 6% in early trading. MFG8 original liquid production plant passes pre-approval inspection by the US FDA.

According to the Securities Times App, WuXi Biologics (02269.HK) surged more than 6% in early trading, with a 4.6% increase at the time of publication to HK $37.3, with a turnover of HK $4.45 billion.